The Defense Threat Reduction Agency (DTRA) recently deleted the publications web page for its Advanced Systems and Concepts Office, inhibiting broad public access to many of the agency’s arms control and proliferation-related studies. But most of the affected DTRA publications have been recovered and reposted in a new DTRA archive on the Federation of American Scientists website.
DTRA’s public affairs office was unable or unwilling to explain the deletion of the ASCO publications web page, except to indicate that it was a policy decision, not an accident. A 2008 version of the now-deleted DTRA page is available via the Internet Archive.
Not all of the suppressed DTRA studies are of equal or enduring interest. Some are perfunctory, derivative or dated. But others provide food for thought, as well as insight into government thinking on various national security topics. A 2007 DTRA-sponsored report entitled “Terrifying Landscapes” (pdf) presented “a study of scientific research into understanding motivations of non-state actors to acquire and/or use weapons of mass destruction.” A 2003 report (pdf) attempted to quantify the occurrence of biological weapons-related information in certain open source scientific publications.
Whatever DTRA’s motivation may have been, impeding public access to archived public records on government websites is an unwholesome act. So we have taken steps to reverse it. See our compilation of selected DTRA reports.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.